XML 24 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Cash Flow Statements - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating Activities      
Net income (loss) $ 79.3 $ 39.8 $ (426.3)
Depreciation and amortization 59.5 65.2 65.4
Stock-based compensation 12.6 14.8 14.1
Goodwill impairment 0.0 0.0 474.0
Net losses (gains) on asset dispositions 3.3 3.7 (6.7)
Changes in operating assets and liabilities, net of acquisition      
Accounts receivable (15.3) 8.4 9.0
Inventories, net of allowance (16.8) 41.0 (20.2)
Prepaid expenses and other assets (2.3) 1.7 (6.0)
Accounts payable 18.8 6.5 14.7
Accrued expenses 11.3 34.0 (14.5)
Deferred income taxes and other (6.2) (26.3) (5.9)
Cash Provided by Operating Activities 144.2 188.8 97.6
Investing Activities      
Capital expenditures (43.2) (29.1) (70.4)
Acquisition of business, net of cash acquired 0.0 (175.0) 0.0
Proceeds from dispositions of property 0.1 3.2 7.8
Cash Used in Investing Activities (43.1) (200.9) (62.6)
Financing Activities      
Line of credit facility proceeds 0.0 72.0 0.0
Line of credit facility repayments 0.0 (72.0) 0.0
Debt issuance costs 0.0 (0.9) 0.0
Debt repayments 0.0 0.0 (51.0)
Purchase of treasury stock (2.5) (0.9) (1.0)
Proceeds from the exercise of stock options and other 4.7 0.4 1.4
Cash Provided by (Used in) Financing Activities 2.2 (1.4) (50.6)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 2.7 (2.3) (3.9)
Increase (Decrease) in Cash and Cash Equivalents 106.0 (15.8) (19.5)
Cash and Cash Equivalents - Beginning of Year 113.7 129.5 149.0
Cash and Cash Equivalents - End of Year 219.7 113.7 129.5
Supplemental Cash Flow Disclosure:      
Cash paid for income taxes 21.4 29.1 43.3
Cash paid for interest 28.7 29.9 32.6
Supplemental Noncash Disclosure      
Capital expenditures included in accounts payable or accrued expenses $ 4.5 $ 5.8 $ 5.6